Abstral is a rapid‑acting fentanyl sublingual tablet approved for the management of breakthrough cancer pain in opioid‑tolerant adults, offering onset of analgesia within minutes due to its highly lipophilic nature and sublingual absorption . It is available in strengths ranging from 100 μg to 800 μg, with an initial recommended dose of 100 μg and careful individual titration to balance efficacy and safety . Abstral carries serious risks—including life‑threatening respiratory depression, addiction, and abuse—and is only dispensed through a restricted REMS program . Metabolism is primarily via CYP3A4, so coadministration with CYP3A4 inhibitors or inducers can markedly alter fentanyl plasma levels; patients must be monitored closely for sedation and respiratory depression . Common adverse effects include nausea, dizziness, and somnolence; patient counseling on proper sublingual administration, avoidance of eating or drinking until complete dissolution, and safe storage is c...
DrugPamphlet Egypt is your comprehensive online guide to medications available in Egypt. We provide detailed commentaries on Egyptian drug brands, covering their indications, dosage, characteristics, side effects, and interactions. Our mission is to empower Egyptians with accurate and reliable pharmaceutical knowledge specific to the local market.